Current filters:


Popular Filters

6726 to 6750 of 7173 results

US health reform helps Medicare recipients save over $3.2 billion


As the second anniversary of the US Affordable Care Act approaches, new data shows that more than 5.1…

HealthcareNorth AmericaPharmaceuticalPricing

New Zealand approves Effient listing for clopidogrel-allergic patients


The Pharmaceutical Management Agency of New Zealand, PHARMAC, has announced reaching agreement with US…

Asia-PacificCardio-vascularEffientEli LillyPharmaceuticalPricingRegulation

Synergy Health buys only Swiss gamma and X-ray irradiation facility


UK-based Synergy Health (LSE: SYR), a provider of outsourced sterilization services to the medical device…

Leoni StuderMergers & AcquisitionsPharmaceuticalSynergy Health

Women Rxed more medicines than men, but take less, US study finds


There is a wide gender divide when it comes to how men and women in the USA are prescribed and adhere…

Cardio-vascularDiabetesHealthcareNorth AmericaPharmaceutical

UCB links with Oxford University for research


he UK subsidiary of Belgian drugmaker UCB (Euronext Brussels: UCB) said yesterday that it has agreed…


MSF urges more compulsory drug licensing in India


In the wake of India granting its first compulsory drug license - to local firm Natco Pharma for a genric…


Flamel Tech acquires US firm Eclat Pharma; reports loss


Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

EMA backs Protelos and Osseor, but with warnings


The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has finalized a review…


Grifols acquires 51% stake in Araclon Biotech


Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

Takeda and Pronova highlight TAK-085 Japanese Ph III trial results


Japanese drug major Takeda Pharmaceutical (TYO: 4502) and Norway-based lipid therapies specialist Pronova…

Cardio-vascularPharmaceuticalPronova BioPharmaResearchTakeda Pharmaceuticals

Sanofi expands in biosurgery, buying Pluromed


French drug major Sanofi (Euronext: SAN) said on Friday that it is to acquire Pluromed, a USA-based medical…

Mergers & AcquisitionsPharmaceuticalPluromedSanofi

Paion now moving in new direction, analysts note


German drug developer Paion AG (FSE: PA8) is moving beyond the bat saliva-derived stroke project desmoteplase,…


Shire to acquire FerroKin BioSciences; drops Replagal BLA


Ireland-headquartered Shire (LSE: SHP) said yesterday that it has signed an agreement to acquire privately-held…

FerroKin BioSciencesMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalRare diseasesRegulationReplagalShire

Novartis unit buys rights to ThromboGenics eye drug


Belgian biopharma company ThromboGenics (Euronext Brussels: THR) revealed this morning that it has entered…


Esbriet offers additional benefit, says German G-BA


USA-based InterMune (Nasdaq: ITMN) says that the German Federal Joint Committee (G-BA) has announced…

EsbrietEuropeInterMunePharmaceuticalPricingRegulationRespiratory and Pulmonary

Positive NICE news for Gilenya for MS and Incivo for hep C


There was good news from the UK drugs watchdog the Institute for Health and Clinical Excellence (NICE)…

Anti-viralsEuropeGilenyaIncivoJanssen-CilagJohnson & JohnsonNeurologicalNovartisPharmaceuticalPricingRegulation

United Therapeutics sues Sandoz over Remodulin patent infringement


United Therapeutics (Nasdaq: UTHR) says that it has filed a law suit in the US District Court for the…

Cardio-vascularGenericsLegalNorth AmericaNovartisPatentsPharmaceuticalRemodulinSandozUnited Therapeutics

GW Pharma and Almirall extend Sativex deal to Mexico


UK-based GW Pharmaceuticals (AIM: GWP) announces that it has signed an amendment to its cannabis-based…

AlmirallFinancialGW PharmaceuticalsLicensingNeurologicalPharmaceuticalSativexSouth America

GlaxoSmithKline off loads more OTC brands


Following its earlier announcement that it intends to divest non-core Consumer Healthcare over-the-counter…

GlaxoSmithKlineMergers & AcquisitionsOmega PharmaPharmaceutical

US gastroenterologists' views on Crohn's disease treatment


The use of anti-TNF biologic agents in the treatment of Crohn's disease (CD) has increased over the past…

Gastro-intestinalsMarkets & MarketingNorth AmericaPharmaceutical

Merck & Co puts up $90 million for new research institute


US pharma giant Merck & Co (NYSE: MRK) has announced a collaboration to create the California Institute…

FinancialMerck & CoPharmaceuticalResearch

6726 to 6750 of 7173 results

Back to top